Ignite Creation Date:
2024-05-05 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00242827
Status:
TERMINATED
Last Update Posted:
2012-08-23
First Post:
2005-09-27
Brief Title:
Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma
Sponsor:
Cephalon
Organization:
Teva Branded Pharmaceutical Products RD Inc
Organization Data
Organization:
Teva Branded Pharmaceutical Products RD Inc
Class:
INDUSTRY
Study ID:
C07012025ONUS
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cephalon
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None